Caster Semenya challenges Olympic gender testing rules

Caster Semenya , a double Olympic champion, said on Monday, March 31, 2026 that she intends to contest the International Olympic Committee’s (IOC) newly introduced gender testing policy for the female category at the Olympics. Her announcement comes days after the IOC presented the new approach, which it framed as a move toward one consistent set of rules for female elite sport following years of differing standards across events and competitions.

The IOC unveiled the policy last week and said it is designed to support a single framework that could be applied broadly. Officials indicated the approach is expected to become a universal regulation for female elite sports competitors, with the stated purpose of standardising eligibility requirements across borders and sporting systems.

In the policy document, the IOC addressed participation by “androgen-sensitive XY-DSD athletes” in female categories, with particular focus on disciplines that depend on strength, power, or endurance. The committee said that permitting such inclusion conflicts with what it described as the core principles of fairness, safety, and integrity in elite competition.

Under the new protocol, athletes would be tested using a cheek swab or saliva analysis. The IOC document states that if an athlete tests positive for the SRY gene, further investigation would follow. The policy describes the SRY gene as being located on the Y chromosome and as initiating the development of male characteristics.

Semenya, who has a Difference of Sexual Development (DSD), said the policy damages women’s rights and dignity. She also rejected the premise that XY-DSD status provides an athletic advantage, saying there is no scientific basis for that claim.

She further said the IOC did not properly consult her or other athletes with DSDs before introducing the policy, and argued that the consultation process did not amount to genuine engagement. Her stated plan to challenge the framework places renewed attention on how the IOC develops eligibility rules at a time when global sports bodies are seeking common standards that can be applied across jurisdictions and competitions.

For international sport governance, the dispute centres on how a universal eligibility framework would be implemented in practice, including testing procedures and follow-up investigations tied to SRY gene findings. The IOC’s expectation that the policy could become widely adopted also means national sporting systems and event organisers may face alignment pressures as they manage compliance, athlete participation processes, and cross-border consistency.

Key uncertainties include how Semenya will proceed with her challenge, whether the IOC adjusts its consultation approach with athletes who have DSDs, and how broadly the framework is adopted as a universal regulation for female elite sports competitors. The IOC has set out the testing steps in its document, while Semenya’s objections focus on rights, dignity, and the basis for claims about competitive advantage.